Julio G. Martinez-Clark

Julio G. Martinez-Clark is co-founder and CEO of bioaccess, a market access consultancy that works with medical device companies to help them do early-feasibility clinical trials and commercialize their innovations in Latin America. Julio is also the host of the LATAM Medtech Leaders podcast: A weekly conversation with Medtech leaders who have succeeded in Latin America. He serves as an advisory board member for Stetson University's Leading Disruptive Innovation program. He has a bachelor's degree in electronics engineering and a master's degree in business administration.


  • 6/6/2023

    El Salvador’s economy has transformed radically over the last half century. In recent years, the country now offers several advantages for medtech clinical research, such as a diverse patient population and a favorable regulatory environment.

  • LATAM’s Regulatory Framework For Medtech Early Feasibility Studies

    Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of urbanization, and more. Here, the author spotlights Colombia, Brazil, and Mexico as the hotspots for medtech feasibility studies in Latin America. 

  • Latin America’s Landscape For Medtech Clinical Trials

    This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America, particularly in Colombia and Paraguay. It also addresses critical success factors and provides recommendations to ensure cost-effective, ethical, and quality EFS and FIH medtech clinical trials in the region.

  • Latin America: A Compelling Region To Conduct Your Clinical Trials

    This article examines the need to conduct clinical trials outside the U.S., addresses the recruitment crisis in the U.S., reviews the incentives for clinical trials overseas, and explores the growth of clinical trials in Latin America. Colombia is highlighted as a country that stands out as ripe with opportunity.

  • Peru’s Growing Medical Device Market In Latin America

    With a population of 32 million, Peru is the fifth most populous country in Latin America. Its medical device market is $390 million, and it imports more than 97% of the medical devices that it uses. This article covers Peru's health system, its medical device regulatory framework, and opportunities for medical device imports.

  • The Large Market For Medical Devices In Colombia May Surprise You

    Colombia has a population of approximately 50 million inhabitants, making it the third most populous country in Latin America after Mexico and Brazil. This article covers the general Colombian health social security system, the current medical device regulatory framework, and the size and trends of the market.

  • Argentina’s Thriving Medical Device Market Amid An Economic Plunge

    Argentina has Latin America's third biggest economy, outdone only by Brazil and Mexico. This article describes the Argentine healthcare system, regulatory framework for medical devices, and related business opportunities and challenges.

  • Medtech In Chile: Currently Latin America’s Easiest Market, But For How Long?

    The total market size of the medical device sector in Chile is about $1.7 billion and has grown a whopping 75 percent since 2017. The nation imports most of its medical devices, and it currently has the easiest regulatory hurdles for medtech in Latin America. However, you should prepare for the upcoming bill that may impact regulation.

  • Brazil’s Medical Device Market: Patient Demographics, Healthcare System, And Outlook

    Government initiatives, favorable demographic conditions, and increased patient purchasing power are among the factors that make Brazil an attractive medtech investment definition. Challenges are weighed against opportunities in this article, the second of a two-part series examining the Brazilian medtech market and factors that affect it.

  • Understanding Medical Device Regulation In Brazil

    Latin America’s largest medical device market is streamlining its registration process and attempting to harmonize with globally recognized standards. Challenges are weighed against opportunities in this article, the first of a two-part series examining the Brazilian medtech market and factors that affect it.